Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Anti-idiotypic antibody to the V3 domain of gp120 binds to vimentin: a possible role of intermediate filaments in the early steps of HIV-1 infection cycle.

Thomas EK, Connelly RJ, Pennathur S, Dubrovsky L, Haffar OK, Bukrinsky MI.

Viral Immunol. 1996;9(2):73-87.

PMID:
8822624
2.
3.
5.
6.

The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.

Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T.

Virology. 1998 Nov 10;251(1):59-70.

7.

A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody.

Laman JD, Schellekens MM, Lewis GK, Moore JP, Matthews TJ, Langedijk JP, Meloen RH, Boersma WJ, Claassen E.

AIDS Res Hum Retroviruses. 1993 Jul;9(7):605-12.

PMID:
8369165
8.
10.
11.
12.

Dual specificity of a human neutralizing monoclonal antibody, specific for the V3 loop of GP120 (HIV-1).

Laisney IL, Strosberg AD.

Immunol Lett. 1999 Apr 15;67(3):185-92.

PMID:
10369125
13.

Cooperativity of neutralizing antibodies directed against the V3 and CD4 binding regions of the human immunodeficiency virus gp120 envelope glycoprotein.

Thali M, Furman C, Wahren B, Posner M, Ho DD, Robinson J, Sodroski J.

J Acquir Immune Defic Syndr. 1992;5(6):591-9.

PMID:
1588493
14.

Two neutralizing anti-V3 monoclonal antibodies act by affecting different functions of human immunodeficiency virus type 1.

Armstrong SJ, McInerney TL, McLain L, Wahren B, Hinkula J, Levi M, Dimmock NJ.

J Gen Virol. 1996 Dec;77 ( Pt 12):2931-41.

PMID:
9000083
17.

Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.

Kang CY, Luo L, Wainberg MA, Li Y.

Biol Chem. 1999 Mar;380(3):353-64.

PMID:
10223338
18.

Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.

Laman JD, Schellekens MM, Abacioglu YH, Lewis GK, Tersmette M, Fouchier RA, Langedijk JP, Claassen E, Boersma WJ.

J Virol. 1992 Mar;66(3):1823-31. Erratum in: J Virol. 1992 Aug;66(8):5175.

20.

Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120.

Matsushita S, Matsumi S, Yoshimura K, Morikita T, Murakami T, Takatsuki K.

J Virol. 1995 Jun;69(6):3333-40.

Supplemental Content

Support Center